EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
26
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Rio Tinto PLC of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 22, 2017 – RIO

NEW YORK, Nov. 29, 2017 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Rio Tinto PLC ("Rio Tinto") (NYSE: RIO ) between October 23, 2012 and February 15, 2013 . You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Southern District of New York. To get more information go to:

http://www.zlk.com/pslra-sbm/rio-tinto-plc-2?wire=3

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

In 2011, Rio Tinto acquired certain Riversdale Mining Limited coal assets in Mozambique that became known as Rio Tinto Coal Mozambique (“RTCM”). The complaint alleges that throughout the Class Period, defendants made false and misleading statements and/or failed to disclose adverse information regarding RTCM’s true value, including that: (1) within months of the purchase, now-former senior executives knew of material problems adversely affecting RTCM’s multi-billion dollar publicly reported valuation; (2) as time passed, the same senior executives knew of additional problems and events that, under applicable accounting rules, required an impairment analysis of RTCM and reductions in its reported valuation; and (3) these executives thwarted the required impairment analysis and continued to tout RTCM’s value to investors.

If you suffered a loss in Rio Tinto you have until December 22, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 16

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 25

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 24

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 22

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 14

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 19

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 20

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading

Top 5 Most Recently Viewed Articles

Wingderm USA Expands Its Footprint at 2025 Aesthetic Show

Updated Category News Views 187

Wingderm USA Takes Center Stage at The Aesthetic Show 2025 Wingderm®, an innovative leader in energy-based medical aesthetic technologies, made a significant impact at The Aesthetic Show (TAS) 2025. This event was a pivotal moment in strengthening Wingderm’s position within the U.S. medical aesthetic market. It was held at a renowned venue and brought together medical...

Continue Reading
INVO Bioscience's Strategic Cash Advance Enhances Financial Stability

Updated Category News Views 259

INVO Bioscience Secures Essential Funding INVO Bioscience, Inc. (NASDAQ:INVO), a prominent player in the medical device sector, has recently embarked on a significant financial maneuver to enhance its operational stability. By entering into a Merchant Cash Advance agreement, the company has obtained $265,000, aiming to bolster its working capital and support various...

Continue Reading
FibroGen Secures $160 Million from Sale to AstraZeneca

Updated Category News Views 120

FibroGen Triumphs with Strategic Sale of China Operations FibroGen, Inc. (NASDAQ: FGEN) is making waves in the biopharmaceutical industry with the recent announcement of its agreement to sell its China subsidiary to AstraZeneca for approximately $160 million. This important financial maneuver not only bolsters FibroGen's financial stability but also positions the company...

Continue Reading
Enzoic Teams Up with CIS CyberMarket for Cybersecurity

Updated Category News Views 76

Enzoic Partners with CIS CyberMarket to Strengthen Cybersecurity Enzoic is excited to announce a strategic partnership with CIS CyberMarket, a program designed to enhance the procurement of cybersecurity solutions for various U.S. government entities, nonprofits, and educational institutions. This collaboration aims to provide those organizations with effective,...

Continue Reading
Fosun's Strategic Sale of German Bank Gathers EUR670 Million

Updated Category News Views 589

Fosun International Completes Strategic Sale of HAL Fosun International Limited has successfully finalized the sale of 99.743% of shares in Hauck Aufhäuser Lampe Privatbank AG (HAL), bringing in EUR670 million. This strategic transaction is a significant part of Fosun's ongoing initiatives to optimize its portfolio and focus on core growth sectors. Transforming Private...

Continue Reading